{"@context":{"@vocab":"https://schema.org/"},"@type":"Drug","@id":"https://api.morvs.ai/drug-product/66302-101#drug","name":"Remodulin","alternateName":"treprostinil","identifier":[{"@type":"PropertyValue","propertyID":"FDA National Drug Code (NDC)","value":"66302-101"},{"@type":"PropertyValue","propertyID":"FDA application number","value":"NDA021272"},{"@type":"PropertyValue","propertyID":"UNII","value":"059QF0KO0R|RUM6K67ESG"},{"@type":"PropertyValue","propertyID":"SPL Set ID","value":"6c80bb38-e8db-4138-9f0d-dbbf9c673185"}],"activeIngredient":"TREPROSTINIL","administrationRoute":["INTRAVENOUS","SUBCUTANEOUS"],"dosageForm":"INJECTION, SOLUTION","manufacturer":{"@type":"Organization","name":"United Therapeutics Corporation"},"drugClass":[],"isAvailableGenerically":false,"legalStatus":"HUMAN PRESCRIPTION DRUG","sameAs":["https://api.morvs.ai/drug-approval/NDA021272","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=6c80bb38-e8db-4138-9f0d-dbbf9c673185","https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=66302-101"],"isAccessibleForFree":true,"license":"https://creativecommons.org/publicdomain/zero/1.0/","_source":{"data_provider":"AI Analytics","brand_name":"MORVS","brand_url":"https://morvs.ai/","data_provider_url":"https://api.morvs.ai","license":"https://creativecommons.org/publicdomain/zero/1.0/","primary_source":"https://open.fda.gov/apis/drug/ndc/","generated_at":"2026-11-01T01:04:59.325Z"}}